Chronic viral hepatitis and risk of lymphoid malignancies: A retrospective twelve-year population-based cohort study in Côte d'Or, France

Digestive and Liver Disease

Volumn 44, Issue 2, 2012, Pages 160-165

  Proby, Claire ^a   Minello, Anne ^b   Quantin, Catherine ^c   Jooste, Valérie ^b   Binquet, Christine ^c   Hägi, Mathieu ^c   Mounier, Morgane ^a   Benzenine, Eric ^c   Hillon, Patrick ^b   Maynadié, Marc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSERM   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Cirrhosis; Lymphoproliferative disorders; Standardized incidence ratio; Viral hepatitis B; Viral hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS C; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LIVER CIRRHOSIS; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZED INCIDENCE RATIO;

FEMALE; FOLLOW-UP STUDIES; FRANCE; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84855725254     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.08.025     Document Type: Article

References (30)

1. http://www.who.int/topics/hepatitis/en/.
2. Prevalence of hepatitis B and hepatitis C in France 2004, InVS. http://apheis.net/publications/2006/prevalence_b_c/vhb_france_2004.pdf.
3. http://www.invs.sante.fr/surveillance/cancers/estimations_cancers/default.htm.
4. Casey R., Brennan P., Becker N., et al. Incidence of familiar cancer history on lymphoid neoplasms risk validated in the large European case-control study epilymph. Eur J Cancer 2006, 42:2570-2576.
5. Duberg A.S., Noldström M., Törner A., et al. Non-Hodgkin's lymphoma and other non-hepatic malignancies in Swedish Patients with hepatitis C virus infection. Hepatology 2005, 41:652-659.
6. Nieters A., Kallinowski B., Brennan P., et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study Epilymph. Gastroenterology 2006, 13:1879-1886.
7. Engels E.A., Chatterjee N., Cerhan J.R., et al. Hepatitis C virus and risk of lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004, 111:76-80.
8. Spinelli J.J., Lai A.S., Kradjen M., et al. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Colombia, Canada. Int J Cancer 2008, 122:630-633.
9. Cowgill K.D., Loffredo C.A., Abdel-Latif S., et al. Case control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 2004, 33:1034-1039.
10. Guida M., D'Elia G., Benvestito S., et al. Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders. Leukemia 2002, 16:2162-2163.
11. Lim S.T., Fei G., Quek R., et al. The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007, 79:132-137.
12. Wang F., Xu R.H., Han B., et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007, 109:1360-1364.
13. Marcucci F., Mele A., Spada E., et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica 2006, 91:554-557.
14. Ulcikas Yood M., Quesenberry C.P., Guo D., et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 2007, 46:107-112.
15. Dal Maso L., Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006, 15:2078-2095.
16. Lakatos P.L., Fekete S., Horanyi M., et al. Development of multiple myeloma in a patient with chronic hepatitis C: a case report and review of the literature. World J Gastroenterol 2006, 12:2297-2300.
17. Percy C., Fritz A., Jack A., et al. International classification of diseases for oncology (ICD-O) 2000, WHO. 3rd ed.
18. Quantin C., Bouzelat H., Allaert A.A., et al. How to ensure data security of an epidemiologic follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inf 1998, 49:117-122.
19. Jaro M.A. Probabilistic linkage of large public health data files. Stat Med 1995, 14:491-498.
20. Quantin C., Binquet C., Allaert F.A., et al. Decision analysis for the assessment of a record linkage procedure: application to a perinatal network. Methods Inf Med 2005, 44:72-79.
21. Breslow N.E., Day N.E. Statistical methods in cancer research, vol. II. The design and analysis of cohort studies (IARC Scientific Publication No. 82) 1987, International agency for research on cancer, Lyon, France.
22. Burra P., Buda A., Livi U., et al. Occurrences of post transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?. Eur J Gastroenterol Hepatol 2006, 18:1065-1070.
23. Schöllkopf C., Ekström Smedby K., Hjalgrim H., et al. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008, 122:1885-1890.
24. La Mura V., De Renzo A., Perna F., et al. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. J Hepatol 2008, 49:557-663.
25. Hermine O., Lefrere F., Bronowicki J.P., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002, 347:89-94.
26. Viswanatha D.S., Dogan A. Hepatitis C virus and lymphoma. J Clin Pathol 2007, 60:1378-1383.
27. Quinn E.R., Chan C.H., Hadlock K.G., et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001, 98:3745-3749.
28. Levy S. Alteration of B cell function by hepatitis C virus. Haematol Rep 2005, 1:55-58.
29. Zein N.N., Rakela J., Krawitt E.L., et al. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity and response to interferon therapy. Ann Intern Med 1996, 125:634-639.
30. Pellicelli M., Zoli V., Remtti D., et al. Hepatology 2009, 50:929A.